IL139140A0 - Cyclopentanone dihydropyridine compounds useful as potassium channel openers - Google Patents
Cyclopentanone dihydropyridine compounds useful as potassium channel openersInfo
- Publication number
- IL139140A0 IL139140A0 IL13914000A IL13914000A IL139140A0 IL 139140 A0 IL139140 A0 IL 139140A0 IL 13914000 A IL13914000 A IL 13914000A IL 13914000 A IL13914000 A IL 13914000A IL 139140 A0 IL139140 A0 IL 139140A0
- Authority
- IL
- Israel
- Prior art keywords
- cyclopentanone
- compounds useful
- potassium channel
- channel openers
- dihydropyridine compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
- C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
- C07C45/298—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with manganese derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/262,441 US6518279B2 (en) | 1999-03-04 | 1999-03-04 | Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
PCT/US2000/005828 WO2000051986A1 (en) | 1999-03-04 | 2000-03-06 | Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
Publications (1)
Publication Number | Publication Date |
---|---|
IL139140A0 true IL139140A0 (en) | 2001-11-25 |
Family
ID=22997528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13914000A IL139140A0 (en) | 1999-03-04 | 2000-03-06 | Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
Country Status (20)
Country | Link |
---|---|
US (1) | US6518279B2 (xx) |
EP (1) | EP1075466A1 (xx) |
JP (1) | JP2003517454A (xx) |
KR (1) | KR20010043295A (xx) |
CN (1) | CN1318053A (xx) |
AR (1) | AR028987A1 (xx) |
AU (1) | AU3616800A (xx) |
BG (1) | BG104999A (xx) |
BR (1) | BR0005189A (xx) |
CA (1) | CA2330541A1 (xx) |
CO (1) | CO5150208A1 (xx) |
HU (1) | HUP0102895A3 (xx) |
IL (1) | IL139140A0 (xx) |
MX (1) | MXPA00010790A (xx) |
NO (1) | NO20005570L (xx) |
PL (1) | PL343883A1 (xx) |
SK (1) | SK18152000A3 (xx) |
TR (1) | TR200003202T1 (xx) |
WO (1) | WO2000051986A1 (xx) |
ZA (1) | ZA200005798B (xx) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6265417B1 (en) | 1997-12-18 | 2001-07-24 | Abbott Laboratories | Potassium channel openers |
US6593335B1 (en) | 1997-12-18 | 2003-07-15 | Abbott Laboratories | Potassium channel openers |
US7074931B2 (en) | 2000-08-02 | 2006-07-11 | Astrazeneca Ab | Process for asymmetric synthesis of substituted 1,4 -dihydropyridines |
US20030045449A1 (en) * | 2001-08-15 | 2003-03-06 | Pfizer, Inc. | Pharmaceutical combinations for the treatment of neurodegenerative diseases |
US20030199578A1 (en) * | 2002-04-19 | 2003-10-23 | Turner Sean C. | Naphthalene amides as potassium channel openers |
ATE451359T1 (de) * | 2006-02-10 | 2009-12-15 | Janssen Pharmaceutica Nv | Neue tricyclische dihydropyrazine als kaliumkanalöffner |
CA2752603C (en) | 2009-02-18 | 2016-04-05 | Bayer Pharma Aktiengesellschaft | Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof |
WO2021253180A1 (en) * | 2020-06-15 | 2021-12-23 | Novartis Ag | Methyl (r) -2- (fluoromethyl) -5-oxo-4-phenyl-4, 5, 6, 7-tetrahydro-1h-cyclopenta [b] pyridine-3-carboxylate and methyl (r) -2- (fluoromethyl) -5-oxo-4-phenyl-1, 4, 5, 7-tetrahydrofuro [3, 4-b] pyridine-3-carboxylate as cav1.2 activators |
US11939316B1 (en) | 2023-11-06 | 2024-03-26 | King Faisal University | 9-(6-flouro-2-hydroxyouinolin-3-yl)-10-(2-hydroxyethyl)-3,6-diphenyl-3,4,6,7,9,10-hexhydroacridine-1,8(2h,5h)-dione as an antimicrobial compound |
US11970478B1 (en) | 2023-11-16 | 2024-04-30 | King Faisal University | 9-(2-hydroxyquinolin-3-yl)-10-(2-hydroxyethyl)-3,3,6,6-tetramethyl-3,4,6,7,9,10-hexahydroacridine1,8(2H,5H)-dione as an antimicrobial compound |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2003148A1 (de) | 1970-01-24 | 1971-07-29 | Bayer Ag | Neue 1,4-Dihydropyridinderivate |
DE3447170A1 (de) | 1984-12-22 | 1986-07-03 | Bayer Ag, 5090 Leverkusen | Mischung unterschiedlicher dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
GB8716971D0 (en) | 1987-07-17 | 1987-08-26 | Pfizer Ltd | Therapeutic agents |
GB8907401D0 (en) | 1989-04-01 | 1989-05-17 | Pfizer Ltd | Therapeutic agents |
GB9220570D0 (en) | 1991-10-21 | 1992-11-11 | Ici Plc | Therapeutic agent |
EP0539154B1 (en) | 1991-10-21 | 1997-12-29 | Zeneca Limited | Acridine-1,8-dione-derivatives as therapeutic agents |
GB9318935D0 (en) | 1992-10-20 | 1993-10-27 | Zeneca Ltd | Heterocyclic derivatives |
DE4313690A1 (de) | 1993-04-27 | 1994-11-03 | Bayer Ag | Kondensierte Chinolyl-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln |
IL135985A0 (en) | 1997-12-18 | 2001-05-20 | Abbott Lab | Potassium channel openers |
-
1999
- 1999-03-04 US US09/262,441 patent/US6518279B2/en not_active Expired - Fee Related
-
2000
- 2000-03-01 CO CO00014719A patent/CO5150208A1/es unknown
- 2000-03-02 AR ARP000100931A patent/AR028987A1/es not_active Application Discontinuation
- 2000-03-06 IL IL13914000A patent/IL139140A0/xx unknown
- 2000-03-06 KR KR1020007012257A patent/KR20010043295A/ko not_active Application Discontinuation
- 2000-03-06 CA CA002330541A patent/CA2330541A1/en not_active Abandoned
- 2000-03-06 AU AU36168/00A patent/AU3616800A/en not_active Abandoned
- 2000-03-06 JP JP2000602213A patent/JP2003517454A/ja not_active Withdrawn
- 2000-03-06 SK SK1815-2000A patent/SK18152000A3/sk unknown
- 2000-03-06 EP EP00914832A patent/EP1075466A1/en not_active Withdrawn
- 2000-03-06 TR TR2000/03202T patent/TR200003202T1/xx unknown
- 2000-03-06 PL PL00343883A patent/PL343883A1/xx not_active Application Discontinuation
- 2000-03-06 CN CN00800760A patent/CN1318053A/zh active Pending
- 2000-03-06 BR BR0005189-6A patent/BR0005189A/pt not_active IP Right Cessation
- 2000-03-06 MX MXPA00010790A patent/MXPA00010790A/es unknown
- 2000-03-06 HU HU0102895A patent/HUP0102895A3/hu unknown
- 2000-03-06 WO PCT/US2000/005828 patent/WO2000051986A1/en not_active Application Discontinuation
- 2000-10-18 ZA ZA200005798A patent/ZA200005798B/en unknown
- 2000-11-03 NO NO20005570A patent/NO20005570L/no not_active Application Discontinuation
- 2000-11-28 BG BG104999A patent/BG104999A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
MXPA00010790A (es) | 2002-06-04 |
SK18152000A3 (sk) | 2001-06-11 |
PL343883A1 (en) | 2001-09-10 |
AU3616800A (en) | 2000-09-21 |
CA2330541A1 (en) | 2000-09-08 |
TR200003202T1 (tr) | 2001-08-21 |
HUP0102895A3 (en) | 2002-01-28 |
AR028987A1 (es) | 2003-06-04 |
JP2003517454A (ja) | 2003-05-27 |
BG104999A (en) | 2001-10-31 |
KR20010043295A (ko) | 2001-05-25 |
BR0005189A (pt) | 2001-01-09 |
NO20005570D0 (no) | 2000-11-03 |
CO5150208A1 (es) | 2002-04-29 |
WO2000051986A1 (en) | 2000-09-08 |
EP1075466A1 (en) | 2001-02-14 |
US6518279B2 (en) | 2003-02-11 |
NO20005570L (no) | 2000-11-03 |
HUP0102895A2 (hu) | 2001-12-28 |
CN1318053A (zh) | 2001-10-17 |
ZA200005798B (en) | 2002-01-18 |
US20020007065A1 (en) | 2002-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5557700A (en) | New uses for potassium channel openers | |
GB2390091B (en) | Bisarylamines as potassium channel openers | |
AU2003294441A1 (en) | 1-aryl-2-hydroxyethyl amides as potassium channel openers | |
AU2408300A (en) | Novel compounds | |
PL343883A1 (en) | Cyclopentanone dihydropyridine compounds useful as potassium channel openers | |
AUPQ441499A0 (en) | Novel compound | |
AU2003295781A1 (en) | Arylcyclopropylcarboxylic amides as potassium channel openers | |
EP1421936A4 (en) | OPENING AGENT FOR THE POTASSIUM CHANNEL | |
WO2002010164A3 (en) | Dihydronaphthyridine- and dihydropyrrolopyridine-derivated compounds as potassium channel openers | |
AU4132200A (en) | Novel compounds | |
AU2109700A (en) | Novel compounds | |
AU2001276148A1 (en) | Door fastening | |
GB2350134B (en) | Improved jar tool | |
AU5078700A (en) | Novel composition | |
AU2001276661A1 (en) | Frame assembly for windows | |
EP1347050A4 (en) | NEW POTASSIUM CHANNELS | |
EP1347049A4 (en) | NEW POTASSIUM CHANNEL | |
AUPQ346999A0 (en) | Substituted diboron compounds | |
AU4156800A (en) | Novel compounds | |
AU2002306716A1 (en) | Bisarylamines as potassium channel openers | |
AU2002253575A1 (en) | Potassium channel opener | |
AU1871101A (en) | Cyclic compound | |
AU2194201A (en) | Novel compound | |
AU2003203035A1 (en) | 1,4-dihydropyridine and pyridine compounds as calcium channel blockers | |
AU4162200A (en) | Novel compounds |